Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lijun Pharmaceutical, primarily known as Xi'an Lijun Pharmaceutical, is a leading Chinese pharmaceutical company specializing in the research, development, and manufacturing of a wide range of medical products. The company is well-regarded for its production of antibiotics, particularly erythromycin and other macrolides, as well as various finished medicines and active pharmaceutical ingredients (APIs). With a history dating back to the 1930s, Lijun has established a significant presence in both the domestic Chinese market and international markets. Its product portfolio spans multiple therapeutic areas, including anti-infectives, cardiovascular health, and respiratory treatments. The company operates large-scale manufacturing facilities that adhere to Good Manufacturing Practice (GMP) standards, ensuring high-quality output for its diverse healthcare offerings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lijuh Pharmaceutical.